1049 LTX-315 confers long term protection in mice re-challenged with murine A20 B-cell lymphoma or murine CT26WT colon carcinoma cells after complete tumour regression following initial treatment

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)70342-8 ◽

2009 ◽

Vol 7 (2) ◽

pp. 101

Author(s):

L.T. Eliassen ◽

K. Camilio ◽

L. Drummond ◽

J.A. Eriksen ◽

O. Rekdal

Keyword(s):

B Cell ◽

Colon Carcinoma ◽

Initial Treatment ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Carcinoma Cells ◽

Tumour Regression ◽

Colon Carcinoma Cells ◽

Complete Tumour

Download Full-text

Long-term outcome of patients with localized gastric marginal zone B-cell lymphoma of MALT following exclusively Helicoabcter pylori eradication therapy

Gastroenterology ◽

10.1016/s0016-5085(01)83717-3 ◽

2001 ◽

Vol 120 (5) ◽

pp. A746-A746

Author(s):

W FISCHBACH ◽

M KOLVEGOEBELER ◽

B DRAGOSICS ◽

M STOLTE ◽

A GREINER

Keyword(s):

B Cell ◽

Marginal Zone ◽

Cell Lymphoma ◽

Eradication Therapy ◽

B Cell Lymphoma ◽

Term Outcome ◽

Long Term Outcome

Download Full-text

Growth speed plays a greater role than MMR status in determining the long-term survival of colon carcinoma cells treated with 5-FU

Zeitschrift für Gastroenterologie ◽

10.1055/s-0029-1241603 ◽

2009 ◽

Vol 47 (09) ◽

Author(s):

B Choudhary ◽

ML Hanski ◽

M Zeitz ◽

C Hanski

Keyword(s):

Colon Carcinoma ◽

Carcinoma Cells ◽

Growth Speed ◽

Term Survival ◽

Long Term Survival ◽

Colon Carcinoma Cells

Download Full-text

MMR status determines short-term apoptosis while growth speed determines necrosis and long-term survival of colon carcinoma cells after 5-FU treatment

Zeitschrift für Gastroenterologie ◽

10.1055/s-0030-1263611 ◽

2010 ◽

Vol 48 (08) ◽

Author(s):

B Choudhary ◽

ML Hanski ◽

M Zeitz ◽

C Hanski

Keyword(s):

Colon Carcinoma ◽

Carcinoma Cells ◽

Growth Speed ◽

Term Survival ◽

Long Term Survival ◽

Colon Carcinoma Cells

Download Full-text

Romiplostim as a Viable and Long-term Remedy for Refractory Immune Thrombocytopenia and Concomitant Small B-Cell Lymphoma

10.37421/jbl.2019.9.236 ◽

2019 ◽

Vol 9 (1) ◽

Author(s):

Germame Ajebo ◽

Paul Dainer ◽

Jeremy Pantin ◽

Nathan Ryan ◽

Charles Bruker

Keyword(s):

B Cell ◽

Immune Thrombocytopenia ◽

Cell Lymphoma ◽

B Cell Lymphoma

Download Full-text

LONG‐TERM ANALYSES FROM L‐MIND, A PHASE II STUDY OF TAFASITAMAB PLUS LENALIDOMIDE (LEN) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (R/R DLBCL)

Hematological Oncology ◽

10.1002/hon.28_2879 ◽

2021 ◽

Vol 39 (S2) ◽

Author(s):

J Duell ◽

K. J Maddocks ◽

E González‐Barca ◽

W Jurczak ◽

A. M Liberati ◽

...

Keyword(s):

B Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Large B Cell Lymphoma ◽

Download Full-text

Long-Term Survival and Gradual Recovery of B Cells in Patients (Pts) with Refractory Large B Cell Lymphoma (LBCL) Treated with Axicabtagene Ciloleucel (Axi-Cel)

Transplantation and Cellular Therapy ◽

10.1016/s2666-6367(21)00520-0 ◽

2021 ◽

Vol 27 (3) ◽

pp. S404-S405

Author(s):

Caron A. Jacobson ◽

Frederick L. Locke ◽

Armin Ghobadi ◽

David B. Miklos ◽

Lazaros J. Lekakis ◽

...

Keyword(s):

B Cells ◽

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Term Survival ◽

Long Term Survival ◽

Large B Cell Lymphoma ◽

Download Full-text

Cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab versus epirubicin, cyclophosphamide, vinblastine, prednisone and rituximab for the initial treatment of elderly “fit” patients with diffuse large B-cell lymphoma: results from the ANZINTER3 trial of the Intergruppo Italiano Linfomi

Leukemia & Lymphoma ◽

10.3109/10428194.2011.621565 ◽

2012 ◽

Vol 53 (4) ◽

pp. 581-588 ◽

Author(s):

Francesco Merli ◽

Stefano Luminari ◽

Giuseppe Rossi ◽

Caterina Mammi ◽

Luigi Marcheselli ◽

...

Keyword(s):

B Cell ◽

Initial Treatment ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Large B Cell Lymphoma ◽

Download Full-text

ESTIMATION OF LONG‐TERM SURVIVAL WITH TAFASITAMAB + LENALIDOMIDE (LEN) IN RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (R/R DLBCL)

Hematological Oncology ◽

10.1002/hon.89_2880 ◽

2021 ◽

Vol 39 (S2) ◽

Author(s):

G Salles ◽

B Goswami ◽

V Bagnardi ◽

D Dey ◽

M Winderlich ◽

...

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Term Survival ◽

Long Term Survival ◽

Large B Cell Lymphoma ◽

Download Full-text

Long-term clinical course of immunotactoid glomerulopathy complicated with diffuse large B-cell lymphoma

CEN Case Reports ◽

10.1007/s13730-021-00648-0 ◽

2021 ◽

Author(s):

Haruka Takahashi ◽

Takashi Sano ◽

Sayumi Kawamura ◽

Keiko Sano ◽

Ryoma Miyasaka ◽

...

Keyword(s):

B Cell ◽

Clinical Course ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Large B Cell Lymphoma ◽

Immunotactoid Glomerulopathy ◽

Download Full-text

MALT lymphoma: epidemiology, clinical diagnosis and treatment

Journal of Medicine and Life ◽

10.25122/jml-2018-0035 ◽

2018 ◽

Vol 11 (3) ◽

pp. 187-193 ◽

Author(s):

Petruta Violeta Filip ◽

◽

Denisa Cuciureanu ◽

Laura Sorina Diaconu ◽

Ana Maria Vladareanu ◽

...

Keyword(s):

Helicobacter Pylori ◽

B Cell ◽

Malt Lymphoma ◽

Cell Lymphoma ◽

Gastric Lymphoma ◽

Eradication Therapy ◽

B Cell Lymphoma ◽

Gastric Malt Lymphoma ◽

Primary gastric lymphoma (PGL) represents a rare pathology, which can be easily misdiagnosed because of unspecific symptoms of the digestive tract. Histologically, PGL can vary from indolent marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT) to aggressive diffuse large B-cell lymphoma (DLBCL). During the years, clinical trials revealed the important role of Helicobacter pylori (H. pylori) in the pathogenesis of gastric MALT lymphoma. Infection with Helicobacter pylori is an influential promoter of gastric lymphomagenesis initiation. Long-term studies revealed that eradication therapy could regress gastric lymphomas.

Download Full-text